Qt Imaging Holdings (QTI) Cash from Financing Activities (2021 - 2026)
Qt Imaging Holdings (QTI) reported Cash from Financing Activities of $159000.0 for Q1 2026, down 97.03% year-over-year from $5.4 million in Q1 2025, and down 98.66% quarter-over-quarter from $11.9 million in Q4 2025.
Qt Imaging Holdings (QTI) Cash from Financing Activities (2021 - 2026) Analysis & Trends
Qt Imaging Holdings (QTI) has 6 years of Cash from Financing Activities data on file, last reported at $159000.0 in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $159000.0, down 97.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.2 million (up 160.65% YoY), and the FY2025 annual result was $18.4 million, up 64.93% from the prior year.
- Cash from Financing Activities slipped to $159000.0 in Q1 2026 per QTI's latest filing, from $11.9 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $11.9 million in Q4 2025 and troughed at -$1.2 million in Q3 2024.
- A 5-year average of $2.3 million and a median of $623485.0 in 2022 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities plunged 540.06% in 2024, then surged 1709.06% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at $675000.0 in 2022, then gained by 18.91% to $802612.0 in 2023, then increased by 13.07% to $907525.0 in 2024, then surged by 1211.84% to $11.9 million in 2025, then sank by 98.66% to $159000.0 in 2026.
- Business Quant data shows QTI's Cash from Financing Activities at $159000.0 in Q1 2026, $11.9 million in Q4 2025, and $571970.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Qt Imaging Holdings | 51.33 Mn | 51.33 Mn | 2.67 Mn | 159,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159,000.00 |
| Mar 31, 2026 | 159,000.00 |
| Dec 31, 2025 | 11.91 Mn |
| Dec 31, 2025 | 11.91 Mn |
| Sep 30, 2025 | 571,970.00 |
| Sep 30, 2025 | 571,970.00 |
| Jun 30, 2025 | 523,716.00 |
| Jun 30, 2025 | 523,716.00 |
| Mar 31, 2025 | 5.35 Mn |
| Mar 31, 2025 | 5.35 Mn |
| Dec 31, 2024 | 907,525.00 |
| Dec 31, 2024 | 907,525.00 |
| Sep 30, 2024 | -1.18 Mn |
| Sep 30, 2024 | -1.18 Mn |
| Jun 30, 2024 | -32,548.00 |
| Jun 30, 2024 | -32,548.00 |
| Mar 31, 2024 | 11.43 Mn |
| Mar 31, 2024 | 11.43 Mn |
| Dec 31, 2023 | 802,612.00 |
| Dec 31, 2023 | 802,612.00 |